Tempus AI TEM and Guardant Health GH are two dominant players in the field of AI-powered precision oncology. Tempus, newly ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Emergent stock is down >40% since my last update. I had given the EBS stock a "Buy" rating but noted that 2025 may be a ...

The UK's FTSE 100 saw its five-week winning streak halted, influenced by global tensions between Israel and Iran, and ...

AstraZeneca PLC closed 22.38% below its 52-week high of £133.88, which the company achieved on September 3rd.

According to Benzinga Pro, AstraZeneca's peer group average for short interest as a percentage of float is 3.86%, which means ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

IonQ (NYSE:IONQ) recently announced a significant achievement with Kipu Quantum, solving the most complex protein folding problem on a quantum computer. This breakthrough likely contributed to the ...

The lawsuit stems from last month's report that claimed Tempus overstates its AI capabilities and engages in "aggressive ...

Metabolism and obesity are the focus of a major research initiative by the University of Gothenburg and AstraZeneca, with the ...

The FTSE 100 faces a stern test of its new high levels this week, with Israel - Iran tensions still running high and Tehran facing warnings from President Trump. Positive news for businesses came, ...